Wellgistics Health (NASDAQ:WGRX - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a note issued to investors on Friday.
Wellgistics Health Price Performance
Shares of WGRX stock traded down $0.15 during mid-day trading on Friday, reaching $1.03. The stock had a trading volume of 1,169,380 shares, compared to its average volume of 2,126,836. Wellgistics Health has a 1-year low of $0.75 and a 1-year high of $7.04. The company has a debt-to-equity ratio of 1.43, a current ratio of 0.36 and a quick ratio of 0.15.
About Wellgistics Health
(
Get Free Report)
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.
Recommended Stories
Before you consider Wellgistics Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Wellgistics Health wasn't on the list.
While Wellgistics Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access